BRPI0008719B8 - Método para radiomarcação de um anticorpo conjugado a um quelante com 90y e ensaio de ligação para determinação da ligação percentual de um anticorpo radiomarcado à sua célula alvo - Google Patents

Método para radiomarcação de um anticorpo conjugado a um quelante com 90y e ensaio de ligação para determinação da ligação percentual de um anticorpo radiomarcado à sua célula alvo

Info

Publication number: BRPI0008719B8
Authority: BR; Brazil
Prior art keywords: radiolabeling; antibody; binding; chelator; determining
Prior art date: 1999-03-01

Application number

Other languages

English (en)

Inventor

Paul Chinn

Ronald Morena

Michael Labarre

John E Leonard

Original Assignee

Idec Pharma Corp

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1999-03-01

Filing date

2000-02-29

Publication date

2021-07-06

2000-02-29 Application filed by Idec Pharma Corp filed Critical Idec Pharma Corp

2000-02-29 Priority to BRPI0017596A priority Critical patent/BRPI0017596B8/pt

2001-12-26 Publication of BRPI0008719A publication Critical patent/BRPI0008719A/pt

2015-07-21 Publication of BRPI0008719B1 publication Critical patent/BRPI0008719B1/pt

2021-07-06 Publication of BRPI0008719B8 publication Critical patent/BRPI0008719B8/pt

Classifications

- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/531—Production of immunochemical test materials
- G01N33/532—Production of labelled immunochemicals
- G01N33/534—Production of labelled immunochemicals with radioactive label
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
- G01N33/60—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances involving radioactive labelled substances

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Immunology (AREA)
Engineering & Computer Science (AREA)
Chemical & Material Sciences (AREA)
Urology & Nephrology (AREA)
Molecular Biology (AREA)
Hematology (AREA)
Biomedical Technology (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Pathology (AREA)
Food Science & Technology (AREA)
General Physics & Mathematics (AREA)
Biochemistry (AREA)
Analytical Chemistry (AREA)
Biotechnology (AREA)
Cell Biology (AREA)
Physics & Mathematics (AREA)
Microbiology (AREA)
Organic Chemistry (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Veterinary Medicine (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Chemical Kinetics & Catalysis (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Peptides Or Proteins (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Investigating Or Analysing Biological Materials (AREA)
Steroid Compounds (AREA)
Packages (AREA)
Agricultural Chemicals And Associated Chemicals (AREA)
Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

BRPI0008719 1999-03-01 2000-02-29 Método para radiomarcação de um anticorpo conjugado a um quelante com 90y e ensaio de ligação para determinação da ligação percentual de um anticorpo radiomarcado à sua célula alvo BRPI0008719B8 (pt)

Priority Applications (1)

Application Number	Priority Date	Filing Date	Title
BRPI0017596A BRPI0017596B8 (pt)	1999-03-01	2000-02-29	método para radiomarcação de um anticorpo conjugado a um quelante com 111in para administração a um paciente

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US09/259,337 US20020102208A1 (en)	1999-03-01	1999-03-01	Radiolabeling kit and binding assay
PCT/US2000/005061 WO2000052473A2 (en)	1999-03-01	2000-02-29	Radiolabeling kit and binding assay

Publications (3)

Publication Number	Publication Date
BRPI0008719A BRPI0008719A (pt)	2001-12-26
BRPI0008719B1 BRPI0008719B1 (pt)	2015-07-21
BRPI0008719B8 true BRPI0008719B8 (pt)	2021-07-06

Family

ID=22984524

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
BRPI0017596A BRPI0017596B8 (pt)	1999-03-01	2000-02-29	método para radiomarcação de um anticorpo conjugado a um quelante com 111in para administração a um paciente
BRPI0008719 BRPI0008719B8 (pt)	1999-03-01	2000-02-29	Método para radiomarcação de um anticorpo conjugado a um quelante com 90y e ensaio de ligação para determinação da ligação percentual de um anticorpo radiomarcado à sua célula alvo

Family Applications Before (1)

Application Number	Title	Priority Date	Filing Date
BRPI0017596A BRPI0017596B8 (pt)	1999-03-01	2000-02-29	método para radiomarcação de um anticorpo conjugado a um quelante com 111in para administração a um paciente

Country Status (35)

Country	Link
US (2)	US20020102208A1 (pt)
EP (2)	EP1192463B1 (pt)
JP (1)	JP4704570B2 (pt)
KR (1)	KR100729247B1 (pt)
CN (1)	CN1235639C (pt)
AT (1)	ATE433108T1 (pt)
AU (1)	AU776747B2 (pt)
BG (1)	BG65690B1 (pt)
BR (2)	BRPI0017596B8 (pt)
CA (2)	CA2362119C (pt)
CY (2)	CY1109335T1 (pt)
CZ (2)	CZ306959B6 (pt)
DE (1)	DE60042326D1 (pt)
DK (2)	DK2112512T3 (pt)
EE (1)	EE05650B1 (pt)
ES (2)	ES2526723T3 (pt)
HK (1)	HK1045730B (pt)
HR (1)	HRP20010714B1 (pt)
HU (2)	HU229627B1 (pt)
IL (1)	IL145109A0 (pt)
ME (1)	ME00782B (pt)
MX (1)	MXPA01008837A (pt)
MY (1)	MY138674A (pt)
NO (2)	NO329142B1 (pt)
NZ (2)	NZ513788A (pt)
PL (1)	PL205780B1 (pt)
PT (2)	PT2112512E (pt)
RS (1)	RS51778B (pt)
RU (1)	RU2251110C2 (pt)
SI (2)	SI1192463T1 (pt)
SK (2)	SK288096B6 (pt)
TW (1)	TWI294969B (pt)
UA (1)	UA78484C2 (pt)
WO (1)	WO2000052473A2 (pt)
ZA (1)	ZA200106943B (pt)

Families Citing this family (98)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6107090A (en)	1996-05-06	2000-08-22	Cornell Research Foundation, Inc.	Treatment and diagnosis of prostate cancer with antibodies to extracellur PSMA domains
US6136311A (en)	1996-05-06	2000-10-24	Cornell Research Foundation, Inc.	Treatment and diagnosis of cancer
MY133346A (en)	1999-03-01	2007-11-30	Biogen Inc	Kit for radiolabeling ligands with yttrium-90
US20020102208A1 (en) *	1999-03-01	2002-08-01	Paul Chinn	Radiolabeling kit and binding assay
US6207858B1 (en) *	1999-03-03	2001-03-27	Idec Pharmaceuticals Corporation	Regioselective synthesis of DTPA derivatives
EP1918305A1 (en)	1999-08-11	2008-05-07	Biogen Idec Inc.	New clinical parameters for determining hematologic toxicity prior to radioimmunotherapy
EP1322383B9 (en)	2000-10-02	2006-09-06	Chiron Corporation	Methods of therapy for b-cell malignancies using antagonist anti-cd40 antibodies
AU2002307037B2 (en) *	2001-04-02	2008-08-07	Biogen Idec Inc.	Recombinant antibodies coexpressed with GnTIII
US7514078B2 (en)	2001-06-01	2009-04-07	Cornell Research Foundation, Inc.	Methods of treating prostate cancer with anti-prostate specific membrane antigen antibodies
WO2002098897A2 (en)	2001-06-01	2002-12-12	Cornell Research Foundation, Inc.	Modified antibodies to prostate-specific membrane antigen and uses thereof
EP1427377A4 (en)	2001-09-20	2006-04-12	Cornell Res Foundation Inc	METHODS AND COMPOSITIONS FOR TREATING OR PREVENTING SKIN DISORDERS USING SPECIFIC BINDING AGENTS FOR A PROSTATE-SPECIFIC MEMBRANE ANTIGEN
ATE408712T1 (de)	2003-01-10	2008-10-15	Millennium Pharm Inc	Verfahren zur bestimmung des wiederauftretens von prostata krebs
TWI353991B (en)	2003-05-06	2011-12-11	Syntonix Pharmaceuticals Inc	Immunoglobulin chimeric monomer-dimer hybrids
EP1638989B1 (en) *	2003-06-25	2008-07-30	Peregrine Pharmaceuticals, Inc.	Method and apparatus for continuous large-scale radiolabeling of proteins
KR101128777B1 (ko)	2003-11-04	2012-04-13	조마 테크놀로지 리미티드	다발성 골수종을 치료하기 위한 길항제 항-ｃｄ４０단클론성 항체의 용도
SI1682177T1 (sl)	2003-11-04	2010-12-31	Novartis Vaccines & Diagnostic	Uporaba antagonističnih anti-CD40 protiteles za zdravljenje kronične limfocitne levkemije
PL1680141T3 (pl)	2003-11-04	2011-04-29	Novartis Vaccines & Diagnostics Inc	Sposoby leczenia guzów litych wykazujących ekspresję antygenu powierzchniowego CD40
ATE447412T1 (de)	2003-11-04	2009-11-15	Novartis Vaccines & Diagnostic	Antagonist-anti-cd40-monoklonale antikörper und anwendungsverfahren
WO2005044307A2 (en)	2003-11-04	2005-05-19	Chiron Corporation	Methods of therapy for b cell-related cancers
JP5421590B2 (ja)	2005-05-18	2014-02-19	ノバルティスアーゲー	自己免疫および／または炎症性成分を有する疾患の診断および治療のための方法
HRP20131066T1 (hr)	2005-07-08	2013-12-06	Biogen Idec Ma Inc.	Sp35 antitijela i njihova upotreba
EP1921982A2 (en) *	2005-08-25	2008-05-21	Koninklijke Philips Electronics N.V.	4d image-based planning methods and apparatus for targeted therapy
US20070117153A1 (en) *	2005-11-23	2007-05-24	Christopher Bieniarz	Molecular conjugate
AR060487A1 (es)	2006-04-21	2008-06-18	Xoma Technology Ltd	Composiciones farmaceuticas de antagonistas del anticuerpo anti- cd40
WO2007149312A2 (en)	2006-06-16	2007-12-27	The Trustees Of The University Of Pennsylvania	Methods and compositions for inhibiting or reducing hair loss, acne, rosacea, prostate cancer, and bph
US9382327B2 (en)	2006-10-10	2016-07-05	Vaccinex, Inc.	Anti-CD20 antibodies and methods of use
WO2008055997A1 (en) *	2006-11-10	2008-05-15	Alphaptose Gmbh	Use of tri-substituted glycerol compounds for the treatment of radiation injuries
CZ300074B6 (cs) *	2006-12-20	2009-01-21	Azacycles S. R. O.	Inteligentní trífunkcní makrokonjugáty a farmaceutický nebo diagnostický prostredek s jejich obsahem
GB0700133D0 (en)	2007-01-04	2007-02-14	Humabs Llc	Human cytomegalovirus neutralising antibodies and use thereof
BRPI0806340B8 (pt)	2007-01-09	2021-05-25	Biogen Idec Inc	anticorpo isolado que se liga especificamente a sp35, seu uso e composição farmacêutica
BRPI0820819B1 (pt) *	2007-12-21	2021-06-08	F. Hoffmann-La Roche Ag	formulação de anticorpos humanizados b-ly 1 e seu uso
CA2729961C (en)	2008-07-09	2018-05-01	Biogen Idec Ma Inc.	Li113, li62 variant co2, anti-lingo antibodies
DK2352759T3 (en)	2008-07-16	2017-12-18	Inst Res Biomedicine	ANTIBODIES THAT NEUTRALIZE HUMAN CYTOMEGALOVIRUS AND USE THEREOF
AU2008359583B2 (en)	2008-07-16	2012-04-05	Institute For Research In Biomedicine	Human cytomegalovirus neutralising antibodies and use thereof
CA2731686C (en)	2008-07-25	2020-04-07	Institute For Research In Biomedicine	Neutralizing anti-influenza a virus antibodies and uses thereof
US8871207B2 (en)	2008-07-25	2014-10-28	Humabs, LLC	Neutralizing anti-influenza A virus antibodies and uses thereof
CN108610416B (zh)	2008-10-13	2022-01-14	生物医学研究所	登革热病毒中和抗体及其用途
JP2012514458A (ja)	2008-12-31	2012-06-28	バイオジェン・アイデック・エムエイ・インコーポレイテッド	抗リンホトキシン抗体
US20110212106A1 (en)	2010-01-20	2011-09-01	Institute For Research In Bioscience	Hiv-1 neutralizing antibodies and uses thereof
SI2835053T1 (sl)	2010-03-12	2016-09-30	Genzyme Corporation	Kombinirana terapija za zdravljenje raka dojke
TW201217527A (en)	2010-07-09	2012-05-01	Biogen Idec Hemophilia Inc	Processable single chain molecules and polypeptides made using same
EP3327032A1 (en)	2010-08-06	2018-05-30	Genzyme Corporation	Vegf antagonist compositions and uses thereof
CN103237902A (zh) *	2010-08-13	2013-08-07	Rdm企业股份有限公司	减少糖的颜色的方法和组合物
SI3045183T1 (sl)	2011-03-11	2018-11-30	Genzyme Corporation	Pegiliran Apelin in njegove uporabe
AU2011373387B2 (en)	2011-07-18	2017-06-29	Institute For Research In Biomedicine	Neutralizing anti-influenza A virus antibodies and uses thereof
UY34317A (es)	2011-09-12	2013-02-28	Genzyme Corp	Anticuerpo antireceptor de célula T (alfa)/ß
EP2793947B1 (en)	2011-12-23	2021-02-03	Innate Pharma	Enzymatic conjugation of polypeptides
CN104350069B (zh)	2012-03-20	2017-12-01	胡默波斯生物医学公司	中和rsv、mpv和pvm的抗体和其应用
HUE037720T2 (hu)	2012-03-28	2018-09-28	Sanofi Sa	Bradikinin B1 receptor ligandumok elleni antitestek
WO2013175276A1 (en)	2012-05-23	2013-11-28	Argen-X B.V	Il-6 binding molecules
RU2522203C2 (ru) *	2012-06-26	2014-07-10	Василий Александрович Ишутин	Способ контроля стерилизации материалов и изделий
US10132799B2 (en)	2012-07-13	2018-11-20	Innate Pharma	Screening of conjugated antibodies
US9790268B2 (en)	2012-09-12	2017-10-17	Genzyme Corporation	Fc containing polypeptides with altered glycosylation and reduced effector function
EP3564259A3 (en)	2012-11-09	2020-02-12	Innate Pharma	Recognition tags for tgase-mediated conjugation
US9701753B2 (en)	2013-03-11	2017-07-11	Genzyme Corporation	Hyperglycosylated binding polypeptides
US11813338B2 (en)	2013-03-12	2023-11-14	The Trustees Of The University Of Pennsylvania	Diagnosing and treating cancer
US10611824B2 (en)	2013-03-15	2020-04-07	Innate Pharma	Solid phase TGase-mediated conjugation of antibodies
EP3010547B1 (en)	2013-06-20	2021-04-21	Innate Pharma	Enzymatic conjugation of polypeptides
CN105517577A (zh)	2013-06-21	2016-04-20	先天制药公司	多肽的酶促偶联
RU2558929C2 (ru) *	2013-08-08	2015-08-10	Федеральное государственное бюджетное учреждение "Научно-исследовательский институт кардиологии" (НИИ Кардиологии)	СПОСОБ ОПРЕДЕЛЕНИЯ СВЯЗЫВАНИЯ РАДИОФАРМПРЕПАРАТА НА ОСНОВЕ ЦИПРОФЛОКСАЦИНА, МЕЧЕННОГО 99mTc C БАКТЕРИЯМИ
HK1221725A1 (zh)	2013-08-13	2017-06-09	Sanofi	纤溶酶原激活剂抑制剂-1(pai-1)的抗体及其用途
US11052177B2 (en)	2013-09-06	2021-07-06	The Trustees Of The University Of Pennsylvania	Antimicrobial polymer layers
SI3052192T1 (sl)	2013-10-02	2020-11-30	Medimmune, Llc	Nevtralizarijoča protitelesa proti-influenci A in njihove uporabe
CN106030304B (zh) *	2014-02-27	2018-02-06	得克萨斯大学体系董事会	用于分离外来体的方法和组合物
WO2015143091A1 (en)	2014-03-19	2015-09-24	Genzyme Corporation	Site-specific glycoengineering of targeting moieties
KR102553870B1 (ko)	2014-03-27	2023-07-10	버드 락 바이오, 인크.	인간 카나비노이드 1(cb1) 수용체 결합 항체
MX392761B (es)	2014-07-15	2025-03-21	Medimmune Llc	Anticuerpos anti-influenza b neutralizantes y usos de los mismos.
US12214038B2 (en)	2014-07-22	2025-02-04	The Trustees Of The University Of Pennsylvania	Compositions and methods for cancer immunotherapy
US20170296650A1 (en)	2014-10-08	2017-10-19	Novartis Ag	Combination of human cytomegalovirus neutralizing antibodies
CA3205824A1 (en)	2014-10-09	2016-04-14	Genzyme Corporation	Glycoengineered antibody drug conjugates
WO2016075546A2 (en)	2014-11-14	2016-05-19	Antonio Lanzavecchia	Antibodies that neutralize ebola virus and uses thereof
SI3220947T1 (sl)	2014-11-18	2021-02-26	Humabs Biomed S.A.	Protitelesa, ki močno nevtralizirajo virus stekline in druge lisaviruse in njihove uporabe
HUE056407T2 (hu)	2015-06-01	2022-02-28	Medimmune Llc	Neutralizáló influenzaellenes kötõmolekulák és alkalmazásaik
MX2018001217A (es)	2015-07-30	2018-09-12	Univ Pennsylvania	Alelos polimorficos de nucleotidos individuales del gen humano dp-2 para la deteccion de la susceptibilidad a la inhibicion del crecimiento del cabello por pgd2.
US10278438B2 (en)	2015-08-31	2019-05-07	Grabbies Media, Llc	Consumer usable device with redeemable member
HK1258218A1 (zh)	2015-09-15	2019-11-08	Board Of Regents, The University Of Texas System	T细胞受体(tcr)结合抗体及其应用
PE20181199A1 (es)	2015-09-30	2018-07-23	Bird Rock Bio Inc	Anticuerpos que se unen al receptor cannabinoide 1 (cb1) humano
WO2017059878A1 (en)	2015-10-07	2017-04-13	Humabs Biomed Sa	Antibodies that potently neutralize hepatitis b virus and uses thereof
SG11201805001UA (en)	2016-01-13	2018-07-30	Medimmune Llc	Method of treating influenza a
WO2018010789A1 (en) *	2016-07-13	2018-01-18	Humabs Biomed Sa	Novel antibodies specifically binding to zika virus epitopes and uses thereof
WO2018193063A2 (en)	2017-04-19	2018-10-25	Institute For Research In Biomedicine	Novel malaria vaccines and antibodies binding to plasmodium sporozoites
CA3061963A1 (en)	2017-05-05	2018-11-08	Vaccinex, Inc.	Human anti-semaphorin 4d antibody
JP7170722B2 (ja)	2017-07-19	2022-11-14	ホフマン・テクノロジーズ・エルエルシー	ストレス関連障害を治療するための組成物
WO2019042555A1 (en)	2017-08-31	2019-03-07	Humabs Biomed Sa	MULTISPECIFIC ANTIBODIES SPECIFICALLY BINDING TO ZIKA VIRUS EPITOPES AND USES THEREOF
CN109550061A (zh) *	2017-09-26	2019-04-02	南京江原安迪科正电子研究发展有限公司	一种用于放射性核素标记抗体的试剂盒及应用
RU2700584C1 (ru) *	2018-12-13	2019-09-18	Общество С Ограниченной Ответственностью "Апто-Фарм"	Способ оценки сродства олигонуклеотида
FI3898668T3 (fi)	2018-12-19	2023-11-28	Humabs Biomed Sa	B-hepatiittivirusta neutraloivia vasta-aineita ja niiden käyttöjä
CN120192414A (zh)	2019-04-03	2025-06-24	建新公司	具有降低的断裂的抗αβTCR结合多肽
CA3152511A1 (en)	2019-08-29	2021-03-04	Vir Biotechnology, Inc.	Antibody compositions and methods for treating hepatitis b virus infection
KR20220148235A (ko)	2020-02-28	2022-11-04	젠자임 코포레이션	최적화된 약물 접합을 위한 변형된 결합 폴리펩티드
AU2021286476A1 (en)	2020-06-11	2023-02-02	Imperial College Innovations Limited	Use of CXCL13 binding molecules to promote peripheral nerve regeneration
JP2024504167A (ja)	2021-01-26	2024-01-30	ヴィア・バイオテクノロジー・インコーポレイテッド	Ｂ型肝炎ウイルス感染を処置するための抗体組成物および方法
TW202430561A (zh)	2022-09-30	2024-08-01	法商賽諾菲公司	抗cd28抗體
WO2024089609A1 (en)	2022-10-25	2024-05-02	Ablynx N.V.	Glycoengineered fc variant polypeptides with enhanced effector function
US12195546B2 (en)	2022-12-19	2025-01-14	Sanofi	CD28/OX40 bispecific antibodies
WO2025177185A1 (en) *	2024-02-20	2025-08-28	Janssen Biotech, Inc.	Materials and methods for biologic affinity analysis
WO2025257408A1 (en)	2024-06-14	2025-12-18	Sanofi	Treatment of solid organ transplant subjects with cd28/ox40 bispecific antibodies
WO2026024319A1 (en)	2024-07-23	2026-01-29	Bird Rock Bio Sub, Inc.	Treatment of obesity and obstructive sleep apnea

Family Cites Families (68)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3994966A (en) *	1972-09-28	1976-11-30	The Board Of Trustees Of The Leland Stanford Junior University	Chelating agents
US4043998A (en) *	1974-10-09	1977-08-23	The Board Of Trustees Of The Leland Stanford Junior University	1-(P-benzenediazonium)-ethylenediamine tetraacetic acid
US4315851A (en) *	1978-12-29	1982-02-16	Kureha Kagaku Kogyo Kabushiki Kaisha	Pharmaceutical composition having antitumor activity
US4348376A (en) *	1980-03-03	1982-09-07	Goldenberg Milton David	Tumor localization and therapy with labeled anti-CEA antibody
US4361544A (en) *	1980-03-03	1982-11-30	Goldenberg Milton David	Tumor localization and therapy with labeled antibodies specific to intracellular tumor-associated markers
US4331647A (en) *	1980-03-03	1982-05-25	Goldenberg Milton David	Tumor localization and therapy with labeled antibody fragments specific to tumor-associated markers
US4460559A (en) *	1980-03-03	1984-07-17	Goldenberg Milton David	Tumor localization and therapy with labeled antibodies specific to intracellular tumor-associated markers
US4460561A (en) *	1980-03-03	1984-07-17	Goldenberg M David	Tumor localization and therapy with labeled antibodies specific to intracellular tumor-associated markers
US4444744A (en) *	1980-03-03	1984-04-24	Goldenberg Milton David	Tumor localization and therapy with labeled antibodies to cell surface antigens
US4622420A (en) *	1980-03-18	1986-11-11	The Regents Of The University Of California	Chelating agents and method
US4472509A (en) *	1982-06-07	1984-09-18	Gansow Otto A	Metal chelate conjugated monoclonal antibodies
US4454106A (en) *	1982-06-07	1984-06-12	Gansow Otto A	Use of metal chelate conjugated monoclonal antibodies
JPS5982222U (ja) *	1982-11-26	1984-06-02	松井　三郎	眼鏡
GB8308235D0 (en)	1983-03-25	1983-05-05	Celltech Ltd	Polypeptides
US4816567A (en)	1983-04-08	1989-03-28	Genentech, Inc.	Recombinant immunoglobin preparations
US4707352A (en)	1984-01-30	1987-11-17	Enzo Biochem, Inc.	Method of radioactively labeling diagnostic and therapeutic agents containing a chelating group
US4636380A (en)	1984-04-23	1987-01-13	Wong Dennis W	Novel physiologic chemical method of labeling protein substances with the radionuclides of indium
US4634586A (en) *	1984-05-21	1987-01-06	The Board Of Trustees Of The Leland Stanford Junior University	Reagent and method for radioimaging leukocytes
US4722892A (en) *	1984-08-31	1988-02-02	Meares Claude F	Monoclonal antibodies against metal chelates
US4824986A (en) *	1985-04-26	1989-04-25	The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services	Metal chelate protein conjugate
US5101827A (en) *	1985-07-05	1992-04-07	Immunomedics, Inc.	Lymphographic and organ imaging method and kit
US4735210A (en) *	1985-07-05	1988-04-05	Immunomedics, Inc.	Lymphographic and organ imaging method and kit
US4926869A (en) *	1986-01-16	1990-05-22	The General Hospital Corporation	Method for the diagnosis and treatment of inflammation
AU593611B2 (en) *	1986-02-14	1990-02-15	Nihon Medi-Physics Co., Ltd.	High molecular compounds having amino groups, and their utilization
US5246692A (en) *	1986-09-05	1993-09-21	The United States Of America As Represented By The Secretary Of Health And Human Services	Backbone polysubstituted chelates for forming a metal chelate-protein conjugate
US4831175A (en) *	1986-09-05	1989-05-16	The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services	Backbone polysubstituted chelates for forming a metal chelate-protein conjugate
US5099069A (en)	1986-09-05	1992-03-24	Gansow Otto A	Backbone polysubstituted chelates for forming a metal chelate-protein conjugate
EP0529645B1 (en) *	1986-09-05	1996-10-23	GANSOW, Otto A.	Process for the preparation of backbone polysubstituted chelates
US5034223A (en) *	1986-10-09	1991-07-23	Neorx Corporation	Methods for improved targeting of antibody, antibody fragments, hormones and other targeting agents, and conjugates thereof
US4921690A (en) *	1986-12-29	1990-05-01	City Of Hope	Method of enhancing the biodistribution of antibody for localization in lesions
IL85035A0 (en) *	1987-01-08	1988-06-30	Int Genetic Eng	Polynucleotide molecule,a chimeric antibody with specificity for human b cell surface antigen,a process for the preparation and methods utilizing the same
US5217704A (en)	1987-11-06	1993-06-08	Abbott Laboratories	Methods and materials for the preparation of metal labelled antibody solutions
AU619218B2 (en)	1987-11-06	1992-01-23	Abbott Laboratories	Methods and materials for the preparation of metal labelled antibody solutions
US5130118A (en)	1987-11-06	1992-07-14	Abbott Laboratories	Methods and materials for the preparation of metal labelled antibody solutions
US4978745A (en)	1987-11-23	1990-12-18	Centocor, Inc.	Immunoreactive heterochain antibodies
US4861579A (en) *	1988-03-17	1989-08-29	American Cyanamid Company	Suppression of B-lymphocytes in mammals by administration of anti-B-lymphocyte antibodies
US4975369A (en)	1988-04-21	1990-12-04	Eli Lilly And Company	Recombinant and chimeric KS1/4 antibodies directed against a human adenocarcinoma antigen
JPH0720989B2 (ja) *	1988-05-25	1995-03-08	アメリカ合衆国	大環状キレート化合物の抱合体と診断的テスト方法
US4923985A (en) *	1988-05-25	1990-05-08	The United States Of America As Represented By The Department Of Health & Human Services	Process for synthesizing macrocyclic chelates
US5059518A (en) *	1988-10-20	1991-10-22	Coulter Corporation	Stabilized lyophilized mammalian cells and method of making same
CA2010511A1 (en)	1989-03-01	1990-09-01	Roberto L. Ceriani	Method of enhancing cancer therapy by administration of unsaturated fatty acids
US5376356A (en) *	1989-03-14	1994-12-27	Neorx Corporation	Imaging tissue sites of inflammation
US5162115A (en) *	1989-05-09	1992-11-10	Pietronigro Dennis D	Antineoplastic solution and method for treating neoplasms
US5460785A (en)	1989-08-09	1995-10-24	Rhomed Incorporated	Direct labeling of antibodies and other protein with metal ions
US5124471A (en) *	1990-03-26	1992-06-23	The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services	Bifunctional dtpa-type ligand
US5219556A (en) *	1990-07-09	1993-06-15	Mallinckrodt Medical, Inc.	Stabilized therapeutic radiopharmaceutical complexes
US5009069A (en) *	1990-08-24	1991-04-23	Molini Alberto E	Method of recovering energy from ocean water
GB9022543D0 (en) *	1990-10-17	1990-11-28	Wellcome Found	Antibody production
WO1992007466A1 (en)	1990-11-05	1992-05-14	Bristol-Myers Squibb Company	Synergistic therapy with combinations of anti-tumor antibodies and biologically active agents
US5208008A (en) *	1990-11-14	1993-05-04	University Of Pittsburgh	Regioselective chemical modification of monoclonal antibodies
AU661296B2 (en) *	1991-01-11	1995-07-20	Cobe Laboratories Inc.	Method of detecting circulating antibody types using dried or lyophilized cells or cell-like material
US5403573A (en) *	1992-04-23	1995-04-04	The Curators Of The University Of Missouri	Radiolabeled protein composition and method for radiation synovectomy
US5541287A (en)	1992-06-09	1996-07-30	Neorx Corporation	Pretargeting methods and compounds
US5716596A (en)	1992-06-23	1998-02-10	Diatide, Inc.	Radioactively labeled somatostatin-derived peptides for imaging and therapeutic uses
US5620675A (en)	1992-06-23	1997-04-15	Diatech, Inc.	Radioactive peptides
US5736137A (en)	1992-11-13	1998-04-07	Idec Pharmaceuticals Corporation	Therapeutic application of chimeric and radiolabeled antibodies to human B lymphocyte restricted differentiation antigen for treatment of B cell lymphoma
DK0752248T3 (da) *	1992-11-13	2000-11-13	Idec Pharma Corp	Terapeutisk anvendelse af kimæriske og radioaktivt mærkede antistoffer mod humant B-lymfocytbegrænset differentieringsantig
US5650134A (en)	1993-01-12	1997-07-22	Novartis Ag (Formerly Sandoz Ltd.)	Peptides
US5595721A (en) *	1993-09-16	1997-01-21	Coulter Pharmaceutical, Inc.	Radioimmunotherapy of lymphoma using anti-CD20
IL113610A0 (en) *	1994-06-03	1995-08-31	Immunomedics Inc	A method of radiolabeling a protein, radiolabeled proteins prepared thereby and diagnostic kits containing the same
US5686578A (en)	1994-08-05	1997-11-11	Immunomedics, Inc.	Polyspecific immunoconjugates and antibody composites for targeting the multidrug resistant phenotype
US5874540A (en)	1994-10-05	1999-02-23	Immunomedics, Inc.	CDR-grafted type III anti-CEA humanized mouse monoclonal antibodies
US5728369A (en) *	1994-10-05	1998-03-17	Immunomedics, Inc.	Radioactive phosphorus labeling of proteins for targeted radiotherapy
US5942210A (en)	1994-11-15	1999-08-24	Cytogen Corporation	Methods for lyoprotecting a macromolecule using tricine
US5830431A (en)	1995-06-07	1998-11-03	Mallinckrodt Medical, Inc.	Radiolabeled peptide compositions for site-specific targeting
US5961955A (en) *	1997-06-03	1999-10-05	Coulter Pharmaceutical, Inc.	Radioprotectant for peptides labeled with radioisotope
MY133346A (en) *	1999-03-01	2007-11-30	Biogen Inc	Kit for radiolabeling ligands with yttrium-90
US20020102208A1 (en) *	1999-03-01	2002-08-01	Paul Chinn	Radiolabeling kit and binding assay

1999
- 1999-03-01 US US09/259,337 patent/US20020102208A1/en not_active Abandoned
2000
- 2000-02-28 MY MYPI20000754A patent/MY138674A/en unknown
- 2000-02-29 NZ NZ513788A patent/NZ513788A/xx not_active IP Right Cessation
- 2000-02-29 MX MXPA01008837A patent/MXPA01008837A/es active IP Right Grant
- 2000-02-29 HU HU0202522A patent/HU229627B1/hu unknown
- 2000-02-29 PT PT91585141T patent/PT2112512E/pt unknown
- 2000-02-29 PT PT00913645T patent/PT1192463E/pt unknown
- 2000-02-29 CA CA2362119A patent/CA2362119C/en not_active Expired - Lifetime
- 2000-02-29 ES ES09158514.1T patent/ES2526723T3/es not_active Expired - Lifetime
- 2000-02-29 CA CA2742153A patent/CA2742153C/en not_active Expired - Lifetime
- 2000-02-29 CN CNB008057397A patent/CN1235639C/zh not_active Expired - Lifetime
- 2000-02-29 SI SI200031036T patent/SI1192463T1/sl unknown
- 2000-02-29 EE EEP200100465A patent/EE05650B1/xx unknown
- 2000-02-29 RS YU61601A patent/RS51778B/sr unknown
- 2000-02-29 PL PL352531A patent/PL205780B1/pl unknown
- 2000-02-29 SI SI200031085T patent/SI2112512T1/sl unknown
- 2000-02-29 DE DE60042326T patent/DE60042326D1/de not_active Expired - Lifetime
- 2000-02-29 BR BRPI0017596A patent/BRPI0017596B8/pt not_active IP Right Cessation
- 2000-02-29 EP EP00913645A patent/EP1192463B1/en not_active Expired - Lifetime
- 2000-02-29 CZ CZ2010-746A patent/CZ306959B6/cs not_active IP Right Cessation
- 2000-02-29 IL IL14510900A patent/IL145109A0/xx not_active IP Right Cessation
- 2000-02-29 DK DK09158514.1T patent/DK2112512T3/en active
- 2000-02-29 AT AT00913645T patent/ATE433108T1/de active
- 2000-02-29 KR KR1020017011093A patent/KR100729247B1/ko not_active Expired - Lifetime
- 2000-02-29 UA UA2001096636A patent/UA78484C2/uk unknown
- 2000-02-29 RU RU2001126400/15A patent/RU2251110C2/ru active
- 2000-02-29 HK HK02107258.0A patent/HK1045730B/zh not_active IP Right Cessation
- 2000-02-29 JP JP2000602634A patent/JP4704570B2/ja not_active Expired - Lifetime
- 2000-02-29 EP EP09158514.1A patent/EP2112512B1/en not_active Expired - Lifetime
- 2000-02-29 HU HU1300275A patent/HU230516B1/hu unknown
- 2000-02-29 HR HR20010714A patent/HRP20010714B1/xx not_active IP Right Cessation
- 2000-02-29 ME MEP-2009-21A patent/ME00782B/me unknown
- 2000-02-29 SK SK91-2010A patent/SK288096B6/sk not_active IP Right Cessation
- 2000-02-29 NZ NZ530868A patent/NZ530868A/en not_active IP Right Cessation
- 2000-02-29 AU AU35052/00A patent/AU776747B2/en not_active Expired
- 2000-02-29 ES ES00913645T patent/ES2328100T3/es not_active Expired - Lifetime
- 2000-02-29 WO PCT/US2000/005061 patent/WO2000052473A2/en not_active Ceased
- 2000-02-29 BR BRPI0008719 patent/BRPI0008719B8/pt not_active IP Right Cessation
- 2000-02-29 DK DK00913645T patent/DK1192463T3/da active
- 2000-02-29 CZ CZ20013126A patent/CZ303262B6/cs not_active IP Right Cessation
- 2000-02-29 SK SK1216-2001A patent/SK287745B6/sk not_active IP Right Cessation
- 2000-03-01 TW TW089103582A patent/TWI294969B/zh not_active IP Right Cessation
2001
- 2001-08-22 ZA ZA200106943A patent/ZA200106943B/xx unknown
- 2001-08-31 NO NO20014245A patent/NO329142B1/no not_active IP Right Cessation
- 2001-09-27 BG BG105957A patent/BG65690B1/bg unknown
2005
- 2005-01-12 US US11/033,439 patent/US7608241B2/en not_active Expired - Fee Related
2009
- 2009-09-01 CY CY20091100912T patent/CY1109335T1/el unknown
2010
- 2010-05-18 NO NO20100717A patent/NO330705B1/no not_active IP Right Cessation
2015
- 2015-02-16 CY CY20151100160T patent/CY1116265T1/el unknown

Also Published As

Publication number	Publication date
HRP20010714A2 (en)	2003-02-28
NO20014245L (no)	2001-10-31
HRP20010714B1 (hr)	2009-01-31
AU3505200A (en)	2000-09-21
CZ303262B6 (cs)	2012-07-04
BRPI0017596B1 (pt)	2015-09-01
WO2000052473A2 (en)	2000-09-08
KR20020021772A (ko)	2002-03-22
UA78484C2 (en)	2007-04-10
IL145109A0 (en)	2002-06-30
HUP0202522A2 (hu)	2002-11-28
PT2112512E (pt)	2015-01-13
ZA200106943B (en)	2002-11-22
TWI294969B (pt)	2008-03-21
DE60042326D1 (de)	2009-07-16
CA2362119C (en)	2012-12-11
WO2000052473A3 (en)	2002-01-31
DK1192463T3 (da)	2009-10-05
RS51778B (sr)	2011-12-31
ES2328100T3 (es)	2009-11-10
NZ530868A (en)	2005-12-23
US20020102208A1 (en)	2002-08-01
PT1192463E (pt)	2009-09-10
PL352531A1 (en)	2003-08-25
RU2251110C2 (ru)	2005-04-27
JP4704570B2 (ja)	2011-06-15
BRPI0008719B1 (pt)	2015-07-21
KR100729247B1 (ko)	2007-06-15
EP2112512A2 (en)	2009-10-28
EP1192463B1 (en)	2009-06-03
ES2526723T3 (es)	2015-01-14
US20050169838A1 (en)	2005-08-04
EP2112512A3 (en)	2009-12-16
CY1116265T1 (el)	2017-02-08
CA2362119A1 (en)	2000-09-08
MY138674A (en)	2009-07-31
ATE433108T1 (de)	2009-06-15
NO20100717L (no)	2001-10-31
CA2742153A1 (en)	2000-09-08
HK1045730A1 (en)	2002-12-06
SI2112512T1 (sl)	2015-02-27
EE200100465A (et)	2002-10-15
YU61601A (sh)	2004-07-15
CZ306959B6 (cs)	2017-10-11
CZ20013126A3 (cs)	2002-07-17
DK2112512T3 (en)	2014-12-15
BRPI0017596A2 (pt)	2011-09-27
BRPI0008719A (pt)	2001-12-26
ME00782B (me)	2012-03-20
SK12162001A3 (sk)	2002-12-03
SK288096B6 (sk)	2013-07-02
NO329142B1 (no)	2010-08-30
NZ513788A (en)	2004-03-26
HU230516B1 (hu)	2016-10-28
CY1109335T1 (el)	2014-07-02
CA2742153C (en)	2015-04-14
NO330705B1 (no)	2011-06-20
JP2002538179A (ja)	2002-11-12
AU776747B2 (en)	2004-09-23
EP1192463A2 (en)	2002-04-03
EE05650B1 (et)	2013-04-15
BRPI0017596B8 (pt)	2023-04-25
HUP0202522A3 (en)	2011-03-28
CN1235639C (zh)	2006-01-11
HK1131208A1 (en)	2010-01-15
MXPA01008837A (es)	2002-05-14
HUP1300275A2 (en)	2002-11-28
WO2000052473A9 (en)	2001-03-08
HK1045730B (zh)	2006-08-18
SI1192463T1 (sl)	2009-10-31
CN1345417A (zh)	2002-04-17
BG105957A (en)	2002-08-30
NO20014245D0 (no)	2001-08-31
HU229627B1 (en)	2014-03-28
EP2112512B1 (en)	2014-11-19
BG65690B1 (bg)	2009-06-30
US7608241B2 (en)	2009-10-27
SK287745B6 (sk)	2011-08-04
PL205780B1 (pl)	2010-05-31

Publication	Publication Date	Title
BRPI0008719B8 (pt)	2021-07-06	Método para radiomarcação de um anticorpo conjugado a um quelante com 90y e ensaio de ligação para determinação da ligação percentual de um anticorpo radiomarcado à sua célula alvo
BRPI0816117B8 (pt)	2021-05-25	anticorpo monoclonal isolado ou fragmento do mesmo, composiçãofarmacêutica, kit para tratamento de desordens relacionadas com colesterol, e, uso de uma proteína de ligação de antígeno ou de um anticorpo monoclonal ou fragmento do mesmo
BRPI9912227B1 (pt)	2013-08-20	método para diagnóstico precoce in vitro de carcinomas e de seus estágios iniciais e kit para realização do método.
WO2005001058A3 (en)	2007-11-08	Identification of biomarkers for liver toxicity
DK1513878T3 (da)	2007-07-16	Sammensætninger og fremgangsmåder til analyse af Apo B48 og Apo B100
AU2003260457A1 (en)	2005-03-10	A method and kit for the quantitative and/or qualitative detection of components in a sample
ATE468533T1 (de)	2010-06-15	Enzym-protein-komplex
Khan et al.	2025	Recent advances in bioanalytical methods for quantification and pharmacokinetic analyses of antibody–drug conjugates
DE602004015953D1 (de)	2008-10-02	Festphase immunochromatographische testverfahren
DE60138192D1 (de)	2009-05-14	Verfahren zur quantifizierung der akt-protein-expression
ATE277352T1 (de)	2004-10-15	Einetenascin-c isoform als marker für neoplasmen
ES2001636A6 (es)	1988-06-01	Metodo para determinar un analito que se fija al "receptor molecular" representado por d-alanil -d-alanina, soporte analitico y estuche analitico para dicho metodo.
WO2007095378A3 (en)	2007-12-21	Mass tagging for quantitative analysis of biomolecules using 13c labeled phenylisocyanate
SE9602234D0 (sv)	1996-06-06	A novel diagnostic method utilizing ECP, and reagents to be used in the methods
WO2007055294A3 (ja)	2007-09-13	同時物質測定方法およびそれに使用する測定用支持体
BR9807766A (pt)	2000-02-22	Uso de metaloprotease de disintegrina, mutantes, fragmentos e semelhantes

Legal Events

Date	Code	Title	Description
2015-07-21	B16A	Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]	Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 21/07/2015, OBSERVADAS AS CONDICOES LEGAIS.
2021-07-06	B16C	Correction of notification of the grant [chapter 16.3 patent gazette]	Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 29/02/00, OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF, QUE DETERMINA A ALTERACAO DO PRAZO DE CONCESSAO
2023-12-26	B21F	Lapse acc. art. 78, item iv - on non-payment of the annual fees in time	Free format text: REFERENTE A 24A ANUIDADE.
2024-01-09	B21H	Decision of lapse of a patent or of a certificate of addition of invention cancelled [chapter 21.8 patent gazette]	Free format text: ANULADA A PUBLICACAO CODIGO 21.6 NA RPI NO 2764 DE 26/12/2023 POR TER SIDO INDEVIDA.